20-10-2020 21:30 via medpagetoday.com

Promising HFrEF Drugs Bomb in HFpEF

(MedPage Today) -- Novel direct soluble guanylate cyclase stimulators did not improve markers of physical function in heart failure with preserved ejection fraction (HFpEF) in two randomized trials.
In the VITALITY-HFpEF trial, mean 24-week change...
Read more »